When the lectin pathway of complement is activated in HSCT, lethal threats emerge.
Endothelial injury plays a significant role in a host of potentially lethal syndromes, including HSCT-associated thrombotic microangiopathy (HSCT-TMA), and can occur prior to, during, and after HSCT.